文献速递临床试验与 GCP基础与转化研究

越橘与燕麦摄入对急性心肌梗死后血脂、炎症及运动能力的影响(BIOAMI):随机双盲安慰剂对照试验方案

Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial.
PubMed 文献 · Trials · 2021-05-10

BIOAMI试验计划纳入900例PCI后急性心肌梗死患者,随机分为越橘粉、高纤维生物处理燕麦麸、两者联合或对照饮料四组,每日两次干预3个月。主要终点为3个月时LDL胆固醇变化组间差异,次要终点包括运动能力、炎症标志物、代谢组学及肠道菌群。

要点

  • 越橘与燕麦均可能改善急性心肌梗死后心血管代谢风险,但需大样本验证。
  • BIOAMI试验将评估越橘、燕麦及联合干预对LDL胆固醇和运动能力的影响。
  • 干预于PCI后5天内启动,每日两次饮用,持续3个月,双盲安慰剂对照。

核心结论

  • 越橘和/或燕麦在标准治疗基础上若能额外降低LDL胆固醇和炎症,可能成为急性心肌梗死后二级预防的经济安全饮食策略。

研究设计与样本

  • BIOAMI为双盲、随机、安慰剂对照临床试验,计划纳入900例急性心肌梗死后接受PCI的患者。
  • 患者随机分入四组:越橘粉饮料、高纤维生物处理燕麦麸饮料、越橘与燕麦联合饮料、无活性成分对照饮料。
  • 干预于PCI后5天内启动,每日饮用两次,持续3个月。

主要发现

  • 原文未报告试验结果,仅描述研究方案。

关键数值与推荐

  • 主要终点为3个月时干预组间LDL胆固醇变化的差异。
  • 主要次要终点为3个月时的运动能力。
  • 其他次要终点包括3个月时炎症生化标志物血浆浓度、代谢组学和肠道菌群组成。

临床怎么用

  • 若试验证实越橘和/或燕麦可额外降低LDL胆固醇和炎症,可作为急性心肌梗死后标准治疗外的辅助饮食策略。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bilberries from Sweden, rich in polyphenols, have shown cholesterol-lowering effects in small studies, and the cholesterol-lowering properties of oats, with abundant beta-glucans and potentially bioactive phytochemicals, are well established. Both may provide cardiometabolic benefits following acute myocardial infarction (AMI), but large studies of adequate statistical power and appropriate duration are needed to confirm clinically relevant treatment effects. No previous study has evaluated the potential additive or synergistic effects of bilberry combined with oats on cardiometabolic risk factors. Our primary objective is to assess cardioprotective effects of diet supplementation with dried bilberry or with bioprocessed oat bran, with a secondary explorative objective of assessing their combination, compared with a neutral isocaloric reference supplement, initiated within 5 days following percutaneous coronary intervention (PCI) for AMI. METHODS: The effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI) trial is a double-blind, randomized, placebo-controlled clinical trial. A total of 900 patients will be randomized post-PCI to one of four dietary intervention arms. After randomization, subjects will receive beverages with bilberry powder (active), beverages with high-fiber bioprocessed oat bran (active), beverages with bilberry and oats combined (active), or reference beverages containing no active bilberry or active oats, for consumption twice daily during a 3-month intervention. The primary endpoint is the difference in LDL cholesterol change between the intervention groups after 3 months. The major secondary endpoint is exercise capacity at 3 months. Other secondary endpoints include plasma concentrations of biochemical markers of inflammation, metabolomics, and gut microbiota composition after 3 months. DISCUSSION: Controlling hyperlipidemia and inflammation is critical to preventing new cardiovascular events, but novel pharmacological treatments for these conditions are expensive and associated with negative side effects. If bilberry and/or oat, in addition to standard medical therapy, can lower LDL cholesterol and inflammation more than standard therapy alone, this could be a cost-effective and safe dietary strategy for secondary prevention after AMI. TRIAL REGISTRATION: ClinicalTrials.gov NCT03620266 . Registered on August 8, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bergh C, Landberg R, Andersson K, et al. Effects of Bilberry and Oat intake on lipids, inflammation and exercise capacity after Acute Myocardial Infarction (BIOAMI): study protocol for a randomized, double-blind, placebo-controlled trial. Trials. 2021. PMID: 33971938. doi:10.1186/s13063-021-05287-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。